Related Experiment Video
Updated: Jun 26, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Characteristics of children hospitalized with infective endocarditis
Michael D Day1, Kimberlee Gauvreau, Stanford Shulman
1Department of Cardiology, Children's Hospital Boston and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Insights
Pediatric infective endocarditis (IE) is shifting towards children without heart conditions. Risk factors for death in children with IE include congenital heart disease, premature birth, and Staphylococcus aureus infections.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Infective endocarditis (IE) in children is a rare condition.
- Most existing data on pediatric IE comes from specialized referral centers.
- This study aims to describe IE characteristics in a broad national pediatric sample.
Purpose of the Study:
- To assess the epidemiological characteristics of infective endocarditis in children.
- To identify trends and risk factors associated with pediatric IE.
- To analyze outcomes and mortality in pediatric IE cases.
Main Methods:
- Analysis of hospital discharge records from the Kids' Inpatient Databases (2000 and 2003).
- Inclusion criteria: patients under 21 years of age with IE diagnosis codes.
- Combined analysis of data from both years.
Main Results:
- A total of 1588 hospitalizations for pediatric IE were analyzed.
- The age distribution showed peaks in infancy and late adolescence.
- Staphylococcus aureus was the most common pathogen (57%), followed by viridans streptococci (20%).
- Preexisting heart disease was present in 42% of patients, predominantly congenital heart disease (81%).
- In-hospital mortality was 5% (84 patients), with higher rates in specific congenital heart defects and prosthetic valve endocarditis.
- Among deaths without preexisting heart disease, S. aureus was prevalent in older children, while prematurity was a factor in infants.
Conclusions:
- Pediatric IE epidemiology shows a trend towards increased cases without preexisting heart disease.
- Congenital heart disease and prosthetic valve endocarditis are significant risk factors for mortality.
- In non-congenital heart disease cases, premature/neonatal age and S. aureus infection are key mortality predictors.
Background:
Infective endocarditis in children is rare, and most reports describe the experience in referral centers. The purpose of our study was to assess the characteristics of children with infective endocarditis in a large national sample.
Methods And Results:
We analyzed hospital discharge records with International Classification of Diseases, ninth revision, codes indicating infective endocarditis among admissions of patients <21 years of age in the Kids' Inpatient Databases 2000 and 2003; analyses for the 2 years were combined. In 1588 hospitalizations, the age distribution was bimodal, with peaks in infancy and late adolescence. The organism was coded in 632 admissions; Staphylococcus aureus was most common (57%), followed by the viridans group of streptococci (20%). Preexisting heart disease was present in 662 patients admitted (42%), among whom 81% had congenital heart disease, 8% had prosthetic valve endocarditis, and 5% had rheumatic heart disease. In-hospital mortality occurred in 84 patients (5%), 38 with preexisting heart disease. Death occurred in 12 of 25 patients (48%) with tetralogy of Fallot and pulmonary atresia, and 4 of 54 (8%) with prosthetic valve endocarditis. Among 46 deaths without preexisting heart disease, S aureus was the causative organism in 13 of 14 patients (93%) beyond infancy; among 32 infants who died, 10 (31%) were premature.
Conclusions:
In 2000 and 2003, we found a continuing shift in the epidemiology of pediatric infective endocarditis toward a higher proportion of children without preexisting heart disease. Risk factors for mortality included some forms of congenital heart disease and, among patients without preexisting heart disease, premature/neonatal age and S aureus as an etiologic agent.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management